SEC Comment Letter 0000000000-24-009136 to MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982) (MMSI)
MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982)
Date: Aug. 9, 2024 · CIK: 0000856982 · Accession: 0000000000-24-009136
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-18592
Letter
August 9, 2024 Fred P. Lampropoulos President, Chief Executive Officer and Director Merit Medical Systems, Inc. 1600 West Merit Parkway South Jordan, UT 84095 Re:Merit Medical Systems, Inc. Definitive Proxy Statement on Schedule 14A Filed April 2, 2024 File No. 000-18592 Dear Fred P. Lampropoulos: We have limited our review of your most recent definitive proxy statement to those issues we have addressed in our comment(s). Please respond to this letter by providing the requested information and/or confirming that you will revise your future proxy disclosures in accordance with the topics discussed below . If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Definitive Proxy Statement on Schedule 14A Pay Versus Performance, page 69 1.Please provide a clear description of the relationship between compensation actually paid and net income, as required by Item 402(v)(5)(ii) of Regulation S-K. Please note that it is not sufficient to state that no relationship exists, even if a particular measure is not used in setting compensation. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
August 9, 2024 Page 2 Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with any questions. Sincerely, Division of Corporation Finance Disclosure Review Program
Show Raw Text
August 9, 2024
Fred P. Lampropoulos
President, Chief Executive Officer and Director
Merit Medical Systems, Inc.
1600 West Merit Parkway
South Jordan, UT 84095
Re:Merit Medical Systems, Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 2, 2024
File No. 000-18592
Dear Fred P. Lampropoulos:
We have limited our review of your most recent definitive proxy statement to those issues
we have addressed in our comment(s).
Please respond to this letter by providing the requested information and/or confirming that
you will revise your future proxy disclosures in accordance with the topics discussed below . If
you do not believe a comment applies to your facts and circumstances, please tell us why in your
response.
After reviewing your response to this letter, we may have additional comments.
Definitive Proxy Statement on Schedule 14A
Pay Versus Performance, page 69
1.Please provide a clear description of the relationship between compensation actually paid
and net income, as required by Item 402(v)(5)(ii) of Regulation S-K. Please note that it is
not sufficient to state that no relationship exists, even if a particular measure is not used in
setting compensation.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
August 9, 2024
Page 2
Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with
any questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program